Whalesbook
Global Trade se Seedha Connection!
Dekho, UPSIDA aur JNPA ke beech ye naya Memorandum of Understanding (MoU) na, Lalitpur Pharma Park ki export capacity ko ekdum badha dega. Isse North India ka industrial hub seedha duniya bhar ke ports se connect ho jayega. UP ke Chief Minister Yogi Adityanath ka dream hai ki state pharma manufacturing mein number one bane, aur ye deal uss direction mein ek bada kadam hai. UPSIDA ke CEO, Vijay Kiran Anand ne kaha hai ki is partnership se investors ko world-class logistics milegi, jisse international markets tak pahunchna aur bhi aasan ho jayega.
Logistics Ka Asli Powerhouse!
Ye strategic tie-up Lalitpur mein bane medicines ko efficiently aur kam kharche mein pahunchane ke liye hai. Dadri-Khurja rail link ko Western aur Eastern Dedicated Freight Corridors (WDFC & EDFC) se connect karke ek advanced multi-modal rail network banaya ja raha hai. Ye network seedha Lalitpur cluster ko JNPA se jodega, jo India ka sabse busy container port hai aur desh ka 50% se zyada containerized cargo handle karta hai. JNPA ki capacity bhi kafi badhi hai, 2025 mein 7.94 million TEUs manage kiye hain aur FY2025-26 ke liye 100 million metric tonnes cargo ka target hai. WDFC ke completion se ye high-speed network aur bhi mazboot hoga, jisse transit time aur logistics cost kam hone ki ummeed hai, jo India mein aksar international standards se zyada hi rehta hai. Ye connectivity UP ke liye pharma hub banne ka ek zaruri hissa hai.
UP Ki Pharma Ambition
Uttar Pradesh apne aap ko pharma aur medtech hub banane mein tezi se kaam kar raha hai, aur Lalitpur Pharma Park uska ek main project hai. Yeh park 1,472 acres mein faila hai aur bulk drugs, APIs, aur formulations ke liye ek modern facility banega, jahan ready-to-use infrastructure aur advanced waste management systems honge. Isse ₹12,000 crore se zyada ka investment aane aur kaafi jobs create hone ki ummeed hai. State ki strategy mein medical device parks aur ek top-tier pharma institute bhi shamil hain, jinko business-friendly policies ka support hai.
Global Challenges Ka Samna
Lekin sab kuch itna bhi smooth nahi hai. Is logistics deal ke fayde hone ke bawajood, Lalitpur Pharma Park aur India ke pharma exports ko badi challenges face karni pad rahi hain. Middle East mein geopolitical tensions ki wajah se freight costs 30-50% tak badh gaye hain aur shipping routes bhi disrupt ho gaye hain. Isse March ke exports mein ₹5,000 crore tak ka nuksan ho sakta hai. Ye volatility raw materials ke import ko bhi affect karti hai, kyuki India APIs ke liye China par bahut depend karta hai, aur finished goods ke export ko bhi. US tariffs bhi ek long-term uncertainty create kar rahe hain. Desh ke andar bhi, infrastructure ki kami, global peers se zyada logistics cost, aur last-mile delivery ki mushkilat abhi bhi DFCs aur JNPA link ke faydon ko kam kar rahi hain. Nifty Pharma Index mein bhi recent weakness dikhi hai, jo investors ki worries ko reflect karta hai.
Aage Ka Raasta
Ye UPSIDA-JNPA pact UP ki pharma export capabilities ko badhane mein ek important step hai, jo direct global market access dega. Ye DFCs aur JNPA expansion jaise national infrastructure projects ke saath align hota hai. Lekin, is initiative ki success is baat par depend karegi ki ye global trade ke complex environment ko kitna manage kar pata hai, jisme geopolitical disruptions aur badalti trade policies shamil hain, aur saath hi domestic supply chain issues ko bhi theek karna hoga. Supply chain resilience aur cost control par focus karna Lalitpur Pharma Park ke global export hub banne ke liye crucial rahega.